Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Meso BioMatrix Acellular Peritoneum Matrix Breast Reconstruction Feasibility Trial

NCT01823107 is registered in ClinicalTrials.gov with Kensey Nash Corporation as lead sponsor.

NCT NCT01823107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01823107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Meso BioMatrix Acellular Peritoneum Matrix Breast Reconstruction Feasibility Trial
Lead sponsor
Kensey Nash Corporation
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2012
Completion date
June 29, 2017
Enrollment
25 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer